Anti-tumour activity in RAS-driven tumours by blocking AKT and MEK
نویسندگان
چکیده
Anti-tumour activity in RAS-driven tumours by blocking AKT and MEK Anthony W. Tolcher, MD, Khurum Khan, MD, Michael Ong, MD, Udai Banerji, MD, PhD, Vassiliki Papadimitrakopoulou, MD, David Gandara, MD, Amita Patnaik, MD, Richard D. Baird, MD, PhD, David Olmos, MD, PhD, Christopher R. Garrett, MD, Jeffrey M. Skolnik, MD, Eric Rubin, MD, Paul Smith, PhD, Pearl Huang, PhD, Maria Learoyd, PhD, Keith Shannon, MS, Anne Morosky, RN, BSN, Ernestina Tetteh, PhD, Ying-Ming Jou, PhD, Kyriakos P. Papadopoulos, MD, Victor Moreno, MD, Brianne Kaiser, MBA MT, Timothy A. Yap, MD, PhD, Li Yan, MD, PhD, Johann S. de Bono, MD, PhD
منابع مشابه
Ras/Raf/MEK/ERK pathway is associated with lung metastasis of osteosarcoma in an orthotopic mouse model.
AIM To identify a marker of osteosarcoma metastasis and to inhibit the marker against the invasive ability of an osteosarcoma cell line (143B). MATERIALS AND METHODS Type I insulin-like growth factor receptor (IGF-1R) and its downstream signalling factors were measured in samples from our orthotopic 143B mouse model by immunohistochemistry. A Matrigel assay was used to assess cell invasion ab...
متن کاملp21-Activated kinase 1 is required for efficient tumor formation and progression in a Ras-mediated skin cancer model.
The RAS genes are the most commonly mutated oncogenes in human cancer and present a particular therapeutic dilemma, as direct targeting of Ras proteins by small molecules has proved difficult. Signaling pathways downstream of Ras, in particular Raf/Mek/Erk and PI3K/Akt/mTOR, are dominated by lipid and protein kinases that provide attractive alternate targets in Ras-driven tumors. As p21-activat...
متن کاملQuinazoline derivative compound (11d) as a novel angiogenesis inhibitor inhibiting VEGFR2 and blocking VEGFR2-mediated Akt/mTOR /p70s6k signaling pathway
Objective(s): We previously reported a series of quinazoline derivatives as vascular-targeting anticancer agents. In this study, we investigated the mechanism underlying the anti-angiogenic activity of the quinazoline derivative compound 11d. Materials and Methods: We examined the effects of quinazoline derivative 11d on vascular endothelial growth factor receptor-2 (VEGFR2) activation via VEG...
متن کاملMEK1 is required for the development of NRAS-driven leukemia
The dual-specificity kinases MEK1 and MEK2 act downstream of RAS/RAF to induce ERK activation, which is generally considered protumorigenic. Activating MEK mutations have not been discovered in leukemia, in which pathway activation is caused by mutations in upstream components such as RAS or Flt3. The anti-leukemic potential of MEK inhibitors is being tested in clinical trials; however, downreg...
متن کاملAnti-leukemia effect of perillyl alcohol in Bcr/Abl-transformed cells indirectly inhibits signaling through Mek in a Ras- and Raf-independent fashion.
PURPOSE Perillyl alcohol (POH) displays preventive and therapeutic activity against a wide variety of tumor models, and it has been suggested that this might be associated with the ability of POH to interfere with Ras prenylation. POH also selectively induces G(1) arrest and apoptosis in Bcr/Abl-transformed hematopoietic cells. Because signaling through Ras is necessary for Bcr/Abl transformati...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2014